Sun Pharma gets Brazil nod for Semaglutide

The semaglutide injectable market in Brazil is around $413 million,

Related stories

business

NTT payments may pursue M&A route into lending

business

Dr. Reddy’s Srikakulam facility gets 3 U.S. FDA observations

business

Hundreds of jobs to go at Jaguar Land Rover

business

Vedanta’s Q1 profit more than doubles, demerges real-estate business